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A B S T R A C T
The propiconazole (Prop) is a fungicide extensively used in agriculture. There are evidences that this
compound may cause endocrine disrupting effects. In vitro studies have demonstrated that Prop inhibits
the activity of CYP 19 (aromatase), responsible for converting androgens into estrogens and also is an
androgen and estrogen receptor antagonist. Therefore, this study evaluated the reproductive toxicity of
Prop treatment in male rats. The Wistar rats were divided in three groups and were treated daily, by
gavage, with corn oil (control group), propiconazole 4 mg/kg (Prop 4) and 20 mg/kg (Prop 20), from post-
natal day 50 to 120. The following were observed: the body weight gain, sexual behavior, testosterone
and estradiol plasmatic levels, organs weight, sperm count and morphology and testicular
histomorphology. There was an increase in abnormal tail morphology sperm, seminal vesicle and vas
deferens weight, and a decrease in estradiol levels in Prop 4 group. Sexual behavior was affected only in
the Prop 20 group. These results suggest that Prop treatment induced alterations in some reproductive
parameters, what could be related with an endocrine disruption.
ã 2015 Elsevier Ireland Ltd. All rights reserved.
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Endocrine disruptors (ED) are referred to as exogenous
substances or mixtures that could interfere with one or more
functions of the endocrine system causing adverse effects in an
organism and/or in the progeny (Craig et al., 2011; Waring and
Harris, 2005; US EPA, 1997).
Several studies have showed a connection between endocrine-
disrupting effects and currently used pesticides. A recent study in
the UK reported that approximately 127 of these substances show
endocrine disrupting action (Mckinlay et al., 2008). In humans, it is
suggested that the exposure to some pesticides decreased sperm
concentration (Perry et al., 2007), and deregulated menstrual
cycles (Axmon et al., 2004; Farr et al., 2004). In rats, tebuconazole
(fungicide), a farm contaminant with ED properties also caused
changes in reproductive function by altering the synthesis ofAbbreviations: Prop, propiconazole; ED, endocrine disruptor; PND, post- natal
day; ER, estrogen receptor; AR, androgen receptor; SIM, sexual incentive
motivation; LST, length of the seminiferous tubules.
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0300-483X/ã 2015 Elsevier Ireland Ltd. All rights reserved.hormones and causing the feminization of males exposed during
gestation and lactation (Taxvig et al., 2007). Thereby, this data
highlights the necessity to study the endocrine disruption of the
pesticides.
Approximately 5.2 billion pounds of pesticides were used
worldwide in both 2006 and 2007 (US EPA, 2011). Along with it, the
interest to study these chemical agents introduced or spread by
humans in the environment has been growing. Since these
contaminants have the potential to affect the endocrine system,
which could interfere with the hormonal production or action,
impairing the sexual identity, fertility or behavior (Castro et al.,
2007).
The azole compounds, such as propiconazole (Prop), are part of
a large family of synthetic fungicides used widely in grain crops
such as wheat, rice, beans, and peanuts (Giavini and Men’egola,
2010; Goetz et al., 2007; Taxvig et al., 2007; Rockett et al., 2006).
The conazoles inhibit the enzyme CYP 51 (lanosterol 14-
a-demethylase) which regulates the ergosterol synthesis, essential
for the fungal cell membrane (Hester et al., 2012; Zarn et al., 2003).
In mammals, the conazoles can affect the expression of cyto-
chrome P450 genes and the activities of P450 enzymes (Sun et al.,
2007), including the CYP 51 enzyme, which is part of the
cholesterol biosynthesis, essential for sex steroids hormones
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in aromatase-expressing MCF-7 breast cancer cells showed that
Prop inhibits CYP19 (aromatase) and acts as an estrogen receptor
(ER) antagonist, as well as an androgen receptor (AR) antagonist in
AR-transfected Chinese Hamster Ovary cells (Kjærstad et al., 2010).
Although, it was demonstrated in vitro that Prop has an anti-
estrogenic activity, conﬂicting results were found in vivo. In a two-
generation study, Prop reduced testis and epididymis weights in F1
pups (INCHEM, 1987). However, the exposure to Prop from intra-
uterine period until adulthood increased testicular weight in the
peripuberal period and the testosterone levels (Goetz et al., 2007).
The lack of consistency among the results shows a clear necessity
of more in vivo researches.
In light of the wide use of pesticides, this study was carried out
to evaluate if the Prop treatment from post-natal day (PND) 50 to
120 could disrupt reproductive functions as sexual behavior,
sperm parameters and hormonal levels in male rats and try to
draw a meaningful conclusion on the safety of use of this
pesticide.
2. Material and methods
2.1. Animals and treatment
Male Wistar rats, from the colony of the State University of
Londrina (UEL), were used for this experiment. They were kept in a
controlled environment with temperature of 21 2 C; 12 h light/
dark cycle (lights on at 6:00 a.m.) and had free access to regular lab
chow (NuvilabTM) and tap water. Males were divided into three
groups (10–15 males/group).
- Control group: received corn oil daily, by gavage, from PND 50 to
PND 120;
- Prop 4.0 mg group (Prop 4): received 4.0 mg/kg of Prop daily, by
gavage, from PND 50 to PND 120;
- PROP 20.0 mg group (Prop 20): received 20.0 mg/kg of Prop
daily, by gavage, from PND 50 to PND 120.
Rats were daily treated at 11:00 a.m–1:00 p.m. Propiconazole
93% pure (CAS no. 60207-90-1) was dissolved in corn oil. AllFig. 1. Diagram of the experimentcompounds were administered in a dosing volume of 2 ml/kg body
weight.
The treatment duration was based on the guideline of OECD 416
(2001), for one entire spermatogenic cycle. Prop was evaluated
toxicologically by the Joint Meeting on Pesticide Residues (FAO/
WHO, 1988), when an acceptable daily intake (in humans) of 0–
0.04 mg/kg/body weight was established on the basis of the no-
observed-adverse-effect level. However, it is assumed that animals
are more resistant (WHO/IPCS, 2005), and for this study the dose of
4 mg/kg that corresponds to 100 times the allowable dose was
chosen. The dose of 20 mg/kg has been proposed based on the
occupational exposure where workers are exposed to higher
concentrations of Prop.
All animal procedures were approved by the State University of
Londrina Ethics Committee for Animal Research (CEUA
16381.2012.45). The experimental protocol is diagramed in Fig. 1.
2.2. Body weight
The body weight was measured every three days during the
treatment period as well as toxicity signs as lacrimation,
piloerection, unusual respiratory pattern and tremors (n = 12–15/
group).
2.3. Sexual behavior evaluation
All behavioral assessments were performed in adult rats
(beginning on PND 90) during the dark phase of a reversed
light/dark cycle, under dim red light. The animals were allowed a
15-day period of adaptation to the reversed light/dark cycle before
the beginning of the evaluations (n = 11–12/group). The observa-
tions always started three/two hours after the onset of darkness
and were recorded by a video camera, linked to a monitor in an
adjacent room.
2.3.1. Copulatory behavior
For the copulatory behavior evaluation (PND 90), each male was
placed into a Plexiglas cage and, after 5 min, a female in natural
estrus was introduced into the cage. During 30 min, the latencies
and numbers of intromissions and ejaculations were observed asal design. PND: postnatal day.
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mount within 10 min, the evaluation was interrupted and repeated
another day. If the male failed again in the second evaluation, it was
considered sexually inactive.
2.3.2. Sexual incentive motivation
The same animals evaluated for copulatory behavior were
submitted to the sexual incentive motivation (SIM) test. In this test,
we used a rectangular arena with 50  50  100 cm (height 
width  length) that presents two openings that communicate
with two small arenas with 25 cm2. The small arenas were
diagonally opposed to each other and the communication with the
main arena is closed with wire mesh. For the test, an estrous female
(sexual incentive) was placed in one of the small arenas and a
sexually active male (social incentive) was placed in the other one.
The ﬂoor of the main arena had two 25 cm2 divisions (zones) in
front of each small arena opening, named sexual incentive and
social incentive zones, respectively. The experimental male was
placed in the center of the main arena and observed for 20 min. The
number of visits and the total time spent visiting each zone was
quantiﬁed, and a preference score was calculated as (time spent in
female zone/total time spent in both incentive zones)  100
(Agmo, 2003).
2.4. Hormonal levels
Male rats were anaesthetized (on PND 120) with sodium
thiopental (40 mg/kg, Cristália, Brazil) and blood samples (n = 9–
10/group) were collected from the abdominal aorta into syringes
containing heparin, always at the same time. Immediately after
collection, blood samples were centrifuged (2500 rpm for 20 min
at 2 C) and the plasma was frozen until assayed. The plasma
testosterone concentration was obtained by microparticle chemi-
luminescence immunoassay (2nd Generation Architect1 Testos-
terone), where the intra-assay coefﬁcient of variation were 4.6%
and sensitivity and 0015 nmol/l, respectively. Analysis of the
estradiol plasma concentration was performed by microparticle
chemiluminescence immunoassay (Architect1 estradiol), the
sensitivity of the assay is 10 pg/ml and the intra-assay error was
5.5%.
2.5. Collection of tissue and organs
The ventral prostate, the right testis, epididymis, vas deferens
and seminal vesicle (without the coagulating gland and full of
secretion) were removed and their weights were determined. The
right testis and epididymis were frozen at 20 C for sperm
counting. The left testis was collected for histomorphometricTable 1
Copulatory behavior of adult male rats at PND 90.
Copulatory behavior Control 
Latency to the ﬁrst intromission (s) 75.0 (22.5–156.0) [9
Number of intromissions until the ﬁrst ejaculation 23.9  5.3
[9/11]
Latency to the ﬁrst ejaculation (s) 577.2  101.9 [8/11] 
Latency of the ﬁrst post-ejaculatory intromission (s) 329.6  23.7 [8/11] 
Number of post-ejaculatory intromissions 18.0 (15.0–24.5) [8/
Number of ejaculations 2.4  0.4
[8/11]
Data are means  SEM (ANOVA completed with Bonferroni), *p < 0.05 compared to Contro
animals in the group is in bracket. Latency to the ﬁrst intromission and number of pos
analyzed by the non-parametric test of Kruskal–Wallis, p > 0.05. Control: corn oil; Propanalysis and the left vas deferens were used for the sperm
morphology.
2.6. Sperm parameters
2.6.1. Daily sperm production per testis, sperm number and transit
time in the epididymis
Right testis was decapsulated and the caput/corpus and cauda
segments from epididymis were separated (n = 10–12/group).
Homogenization-resistant testicular spermatids (stage 19 of
spermiogenesis) and sperm in the caput/corpus epididymis and
cauda epididymis were assessed as described previously by Robb
et al. (1978) with adaptations of Fernandes et al. (2007). Mature
spermatids were counted in a Neubauer chamber. To calculate
daily sperm production (DSP), the number of spermatids at stage
19 was divided by 6.1, which is the number of days in one
seminiferous cycle when these spermatids are present in the
seminiferous epithelium. Sperm transit time through the epididy-
mis was determined by dividing the number of sperm in each
segment by the DSP.
2.6.2. Sperm morphology
The evaluation of sperm morphology was performed according
to Fernandes et al. (2007). Sperm were recovered from the left vas
deferens by ﬂushing with 1 ml of formol-saline (10%) and smears
were prepared on histological slides that were left to dry for 90 min
(n = 10–12/group). It was analyzed 200 spermatozoa per animal in
a phase-contrast microscope (400 magniﬁcation) (Seed et al.,
1996). Morphological abnormalities were classiﬁed into two
general categories: head morphology (without characteristic
curvature or isolated form, i.e., no tail attached) and tail
morphology (broken or isolated or coiled i.e., no head attached)
(Filler, 1993).
2.7. Biometric parameters and histological analysis of testis
The left testis (n = 8–9/group) was promptly dissected, weighed
and ﬁxed by immersion in Bouin’s solution for 24 h before being
stocked in ethanol at 70 C. Testis were cut into tissue fragments,
dehydrated in increasing concentrations of ethanol, and embedded
in parafﬁn. Blocks were sectioned at 7 mm and stained with
hematoxylin–eosin.
The average tubular diameter was obtained in a linear reticule
micrometer (OSM-223287, Olympus) coupled to an ocular micro-
scope (100 magniﬁcation). It was measured ﬁfteen cross sections
of round sex cord/seminiferous tubule per animal chosen
randomly, with round or rounded proﬁles.
The composition of volumetric data of testicular parenchyma
was obtained using a 100-intersection point counting grid placedProp 4 Prop 20
/11] 81.0 (46.0–166.0) [7/10] 142.5 (115.8–175.3) [8/12]
26.1  2.9
[7/10]
31.6  4.9
[8/12]
528.0  75.3 [7/10] 1043.8  146.0* [6/12]
277.0  14.4 [7/10] 309.4  17.2
[5/12]
11] 28.0 (21.0–40.0) [7/10] 18.0 (8.0–18.0)
[5/12]
2.6  0.3
[7/10]
1.7  0.3
[5/12]
l and Prop 4. The number of animals that displayed the behavior per total number of
t-ejaculatory intromissions are presented as median (1 and 3 quartile) and was
 4: propiconazole 4 mg/kg/day; Prop 20: propiconazole 20 mg/kg/day
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randomly (1000 points) for each animal at 100 of ﬁnal
magniﬁcation and scored.
The volume of each component of the testis was determined as
the product of the volume density and testis volume. Because the
testis density is nearly 1.0 (1.03–4), for subsequent morphomet-
ric calculations, the testis weight was considered equal to its
volume (França and Godinho, 2003). To obtain a more precise
measure of testis volume, the capsule (6.5%) was excluded from
the weight.
The total length of the seminiferous tubules (LST) in meters per
testis was estimated from the volume occupied by seminiferous
tubules and the tubular diameter measurement obtained for each
animal, according to the following formula: LST = VTTS/pR2, where
VTTS = total volume of the seminiferous tubules; pR2 = area of
transverse section of seminiferous tubules (R = tubular diameter/2)
(Attal and Courot, 1963; Dorst and Sajonski, 1974).
2.8. Statistical analysis
Initially, an exploratory analysis was conducted to evaluate
normal distribution (Shapiro–Wilk test) and homogeneity of
variance (Levene’s test) of each variable. Variables that presented
normal distribution and homogeneity of variance were analyzed
by ANOVA complemented with Bonferroni post-hoc test. Con-
versely, for other variables Kruskal–Wallis complemented with
Dunn’s test were performed. Analysis of covariance (ANCOVA) was
used to detect the effect of each treatment on organs weight after
adjusting for ﬁnal body weight. Differences were considered
signiﬁcant if p < 0.05.
3. Results
In Table 1 are presented the copulatory behavior parameters.
There was an increase in latency to the ﬁrst ejaculation in Prop 20
compared to Control group, but not in Prop 4 [F (2, 18) = 6.388,
p = 0.008]. No statistical difference was observed in sexual
motivation when compared to Control (Table 2).
No statistical difference was observed in testosterone levels
within groups, however, it was noted a decrease in the plasma
concentration of estradiol in Prop 4 when compared to Control [F
(2, 25) = 3.421, p = 0.049] (Table 3).
Body weight gain, ﬁnal body and reproductive organs weight
are presented in Table 4. ANCOVA complemented with Bonferroni,
using the ﬁnal body weight as co-variance, showed an increase in
vas deferens [F (2, 35) = 4.282, p = 0.022] and seminal vesicles (full/
empty) [F (2, 35) = 7.554, p = 0.002]/[F (2, 35) = 4.022, p = 0.027]
weight in Prop 4 when compared to Control group (p < 0.05).
Sperm parameters are presented in Table 5. There was an
increase in abnormal tail morphology in Prop 4 [X2 (2) = 7.728,
p = 0.021] when compared to control group.
ANOVA was performed to compare testis morphometric
parameters (Table 6) and no difference was observed between
the groups (p<0.05).Table 2
Sexual incentive motivation of adult male rats at PND 90.
Parameters Control [11] 
Time spent in male zone (s) 238.00 (190.50–300.00) 
Time spent in female zone (s) 589.00 (453.50–681.00) 
Number of visits in male zone 17.00 (15.50–19.00) 
Number of visits in female zone 20.00 (16.50–24.50) 
Preference Score 71.83 (55.64–78.61) 
Data is presented as median (1st–3rd quartile), p > 0.05, Kruskal–Wallis complemented w
corn oil; Prop 4: Propiconazole 4 mg/kg/day; Prop 20: propiconazole 20 mg/kg/day.4. Discussion
Prop is a fungicide extensively used in agriculture. There are
evidences that this compound may cause endocrine disrupting
effects (Rockett et al., 2006; Goetz et al., 2007; Sun et al., 2007).
Thus, the aim of this study was to evaluate the effects of Prop on
reproductive functions in adulthood.
It is known that the presence of a toxic substance could
interfere with the growth pattern of an animal (Johnson, 1981).
Although a decrease in body weight with a higher dose (250 mg/
kg) was observed (Goetz et al., 2007), in the present study, Prop did
not affect the body weight gain. It is suggested that the treatment
with Prop, in both doses, did not cause toxicity once no signs were
observed (i.e., decreased body weight, lacrimation, piloerection,
unusual respiratory patterns and tremors).
Although the body weight was not altered, the treatment
increased the seminal vesicle (full/empty) and vas deferens
weights in Prop 4 group. It is known that the increase in the
seminal vesicle growth is used to detect an anti-estrogenicity of a
substance (Skarda and Köhlerová, 2006). In this sense, it suggests
that in the present study that Prop has this action, once in
aromatase-expressing MCF-7 breast cancer cell, Prop showed an
anti-estrogenic effect (Kjærstad et al., 2010). Supporting this
hypothesis, the testosterone levels were not signiﬁcantly altered,
but there was a decrease in estradiol levels in the same group.
Additionally, another hypothesis is the alteration in the contractil-
ity and/or excitability of the smooth muscle of vas deferens and
seminal vesicle, since it is known that the reproductive hormonal
status inﬂuences in the genital smooth muscle responses (Martins
and Valle,1939; Wilcke,1937). It was demonstrated by Picarelli and
Valle (1969) that estrogens can facilitate the interaction between
sympathomimetic and parasympathomimetic drugs and their
receptors at the level of the smooth muscle of male genitals. Thus,
in the present study, it is suggested that lower estrogenic activity
could impair the contractility and excitability mechanism, and
probably increase the ﬂuid in the seminal vesicle and vas deferens.
In addition to androgens, testis were also a source of estrogens and
the intratesticular levels of estrogen could be higher than in the
plasma of adult females (Carreau, 2001; Hess, 2000). Although the
role of androgens on males reproductive system is well character-
ized, the role of estrogens on male is not well understood, and
further research is necessary for a better understanding of
mechanism involved. The two forms of nuclear ER, ERa and
ERb, are found in male rat reproductive organs. Immunoreaction
studies showed that ERa was localized in few cell types, while ERb
is abundantly express through the rat reproductive tract and
accessory glands (Yamashita, 2004; Hess et al., 1997; Saunders
et al., 1997). It was also reported the expression of ERa, but mostly
ERb in multiple cells involved in spermatogenesis in rodents (Van
Pelt et al., 1999; Saunders et al., 1998). Moreover, our further
ﬁndings showed that the treatment with Prop 4 altered tail sperm
morphology (increasing tail abnormality) and it could also be
related with an anti-estrogenic activity, once all the testicular cells
involved in the spermatogenesis have an ER. Besides, the normalProp 4 [10] Prop 20 [12]
217.50 (185.50–250.25) 249.00 (171.75–366.25)
683.00 (632.50–689.50) 636.50 (557.25–718.50)
19.00 (16.00–20.00) 17.00 (12.50–17.50)
22.00 (19.25–25.50) 19.50 (14.75–21.25)
75.87 (69.66–79.59) 71.63 (60.35–80.47)
ith Dunn test. Numbers in brackets represent the number of animal/group. Control:
Table 3
Testosterone and estradiol levels from male rats ate PND 120.
Control Prop 4 Prop 20
Testosterone (ng/ml) 10.60 (6.87–35.99) [10] 6.86 (3.20–13.30) [10] 4.05 (3.76–9.96) [9]
Estradiol (pg/ml) 22.00  1.18 [9] 17.11  0.87* [9] 19.90  1.63 [10]
Testosterone data are presented as median (1st–3rd quartile), p > 0.05, Kruskal–Wallis complemented with Dunn test. Estradiol data are means  SEM, compared with ANOVA
complemented with Bonferroni. Numbers in brackets represent the number of animal/group. Control: corn oil; Prop 4: propiconazole 4 mg/kg/day; Prop 20: propiconazole
20 mg/kg/day.
Table 4
Body weight gain, ﬁnal body weight and wet weight of organs from male rats at PND 120.
Control [12] Prop 4 [12] Prop 20 [15]
Body weight gain (g) 191.50 (183.8–200.6) 194.40 (188.6-206.0) 202.10 (182.9-217.5)
Final body weight (g) 405.40  7.14 423.09  7.48 426.37  9.60
Organs weight (g)
Testicle (right) 1.598  0.042 1.543  0.041 1.593  0.037
Vas deferens 0.091  0.004 0.109  0.004* 0.099  0.004
Epididymis 0.595  0.012 0.604  0.012 0.617  0.010
Prostate 0.440  0.026 0.506  0.025 0.447  0.023
Full seminal vesicle 0.748  0.028 0.900  0.028* 0.801  0.025
Empty seminal vesicle 0.221  0.015 0.279  0.014* 0.252  0.013
Body weight gain are presented as median (1st–3rd quartile), p > 0.05, Kruskal–Wallis complemented with Dunn test. Data are means  SEM, ﬁnal body weight were
compared with ANOVA complemented with Bonferroni and organs weight were considered by analysis of covariance (ANCOVA) on ﬁnal body weight (*p < 0.05 compared to
Control). Numbers in brackets represent the number of animal/group. Control: corn oil; Prop 4: propiconazole 4.0 mg/kg; Prop 20: propiconazole 20.0 mg/kg.
Table 5
Sperm parameters of adult male rats at PND 120.
Parameters Control [10] Prop 4 [10] Prop 20 [12]
No. of spermatids (106/testis) 155.54  7.64 166.90  7.44 172.03  7.28
No. of spermatids (106/g/testis) 99.91  5.32 106.27  5.14 106.52  4.72
Daily sperm production (x106) 25.49  1.25 27.36  1.22 28.20  1.19
No. of spermatozoa  106/caput + corpus of epididymis 110.36  10.26 93.48  6.43 102.44  7.68
No. of spermatozoa  106/g/caput + corpus of epididymis 404.20 (337.90–449.20) 355.70 (324.00–387.30) 377.90 (309.80–480.10)
No. of spermatozoa  106/cauda of epididymis 214.00  8.60 210.23  14.47 203.82  15.75
No. of spermatozoa  106/g/cauda of epididymis 930.91  73.90 851.15  46.21 827.75  38.14
Sperm transit time (days) through caput/corpus of epididymis 4.43  0.44 3.48  0.28 3.66  0.27
Sperm transit time through cauda of epididymis (days) 8.00  0.23 7.81  0.65 7.25  0.55
Abnormal head morphology sperm (%) 23.15 [13] (16.80–33.51) 32.62 [14] (17.07–47.67) 26.32 [15] (18.96–36.57)
Abnormal tail morphology sperm (%) 5.37 [13] (3.33–6.76) 11.65* [14] (5.77–20.52) 9.39 [15] (4.90–14.50)
Data are means  SEM and median (1st–3rd quartile). Numbers in brackets represent the number of animal/group. *p < 0.05 compared to control (Kruskal–Wallis
complemented with Dunn). Control: corn oil; Prop 4.0: propiconazole 4.0 mg/kg; Prop 20.0: propiconazole 20.0 mg/kg.
Table 6
Morphometric parameters of testis from male rats at PND 120.
Control [9] Prop 4 [9] Prop 20 [8]
Testicular volume (ml) 1.46  0.03 1.47  0.02 1.50  0.03
Volume of interstitial content (ml) 0.56  0.02 0.55  0.02 0.60  0.02
Volume of seminiferous tubules (ml) 0.89  0.02 0.091  0.02 0.89  0.02
Diameter of seminiferous tubules (mm) 267.64  6.29 269.52  5.43 263.74  6.88
Total length of seminiferous tubules (m) 16.13  0.85 16.16  0.65 16.72  1.04
Data are means  SEM and was analyzed by ANOVA complemented with Bonferroni. p < 0.05. Numbers in brackets represent the number of animal/group. Control: corn oil;
Prop 4.0: Propiconazole 4.0 mg/kg; Prop 20.0: propiconazole 20.0 mg/kg.
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the high concentration of estrogen (Stocco, 2012). Conversely,
Goetz et al. (2007) demonstrated that Prop treatment at the doses
of 100, 500 and 2500 ppm (approximately 10, 50 and 240 mg/kg/
day) did not affect the sperm morphology. The divergent results
could be related to the sperm collection, since the researchers
collected it from epididymis cauda. In the present study, the
alteration in sperm morphology could also be linked with the
contractility of the duct.Regarding testis histology, Prop treatment did not alter the
morphometric parameters, as an indication that testicular
functions was not altered, in accordance with previous study
designed by Goetz et al. (2007).
On the other hand, the males rats treated with Prop at the dose
of 20 mg/kg presented impairment in the sexual behavior,
observed by an increase in the latency to the ﬁrst ejaculation.
The male sexual behavior, among several vertebrates species, is
activated by testosterone but also requires the estrogenic activity
60 N.O. Costa et al. / Toxicology 335 (2015) 55–61(Naftolin et al., 1975), since this behavior is reduced by systemic
administration of antiandrogens, antiestrogens and aromatase
inhibitors (Roselli and Resko, 1997). Although, a statistical
difference in testosterone levels between the groups was not
observed, the animals treated with Prop 20 mg/kg had lower
testosterone levels, which could have impaired the copulatory
behavior. The maintenance of normal male sexual behavior
depends on the synergistic action of androgens and estrogens,
so these results also suggest that Prop had an anti-androgenic
effect. Regarding the sexual incentive motivation test, treatment
with Prop did not change the parameters analyzed.
EDs can produce simultaneous action at different interrelated
levels of endocrine systems. In this study, the different dose
response patterns between the Prop groups does not explain which
mechanism could be involved and our results underscore the need
for further research geared towards understanding the mecha-
nisms involved. It is known that azole fungicides can act via
multiple modes, including direct interaction with steroid hormone
receptors, or altered steroidogenesis (Kjeldsen et al., 2013;
Kjærstad et al., 2010). In this way, Prop may be involved in
multiple steps of steroidogenesis, since Prop decreased progester-
one, testosterone and estradiol production in H295R cell (Taxvig
et al., 2013), as well as, inhibiting the aromatase activity (Laville
et al., 2006; Sanderson et al., 2002; Vinggaard et al., 2000).
However, dose–response pattern of a dual effect of Prop on
aromatase activity was also observed (Kjeldsen et al., 2013),
suggesting both inhibiting and inducing effects on this enzyme in
human JEG-3 cells. It was observed by Goetz et al. (2007) an
increased in the testosterone levels, on the other hand Prop 20
seems to have decreased testosterone in the present study. The
divergence among the results may be explained by the multiples
modes of action of Prop on reproductive system.
Then, our results indicate that treatment with Prop may have an
endocrine disrupter effect and could cause damage to the male
reproductive functions. Therefore, there is a need for further
studies, since the population is continuously exposed to this
compound.
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